检索

标题
作者
Albumin-bound paclitaxel in the treatment of metastatic breast cancer
Artamonova E.
Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature
Kovalenko Z., Kekeeva T., Lyadov V.
The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer
Frolova M.
Rare morphological forms of breast cancer: features of surgical approach
Vysotskaya I., Letyagin V., Kolyadina I., Martynova G.
Neoadjuvant systemic therapy of HER2-positive breast cancer
Frolova M.
Intrahepatic cholangiocellular carcinoma (review)
Zharikov Y., Shevchenko T., Zhao A.
Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib
Smolin A., Gorbacheva A.
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.
Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial
Ahmetzanov F., Ahmetzanova F.
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program
Poddubnaya I., Bichurina S., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Petrukhnenko V., Sivunova I., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.
New chemotherapy options for triple-negative breast cancer (review of literature)
Sekundova M., Zdvizhkov A., Borisov V.
Gefitinib – terapiya vybora 1-y linii nemelkokletochnogo raka legkogo u bol'nykh s nalichiem mutatsiy v gene EGFR
Bolotina L.
Prolongirovannaya blokada angiogeneza pri metastaticheskom kolorektal'nom rake (novye dannye)
Artamonova E.
Combined and complex treatment options for patients with operable rectal cancer
Barsukov Y., Tkachev S., Mamedli Z., Kuzmichev D., Aliev В., Kim D.
Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo
Poddubnaya I.
Kombinirovannoe lechenie metastazov kolorektal'nogo raka v pechen' s primeneniem regionarnoy khimioterapii
Kotiv B., Alent'ev S., Dzidzava I.
Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin
Borisova E., Voronina I., Gutorov S.
Opyt primeneniya preparata Eloksatin pri kolorektal'nom rake
Voznyy E., Popov A., Astrakhankina T., Grishunenkova E., Polyanskaya E.
Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei
Khokhlova S., Romanov I., Gorbunova V., Matyakin E.
Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy
Khvastunov R., Kireev A., Nikol'skiy I., Suvorov V.
Melkokletochnyy rak legkogo: chto izmenilos' za poslednie 30 let?
Bychkov M.
Pemetreksed (alimta)
Tyulyandin S.
Sravnitel'naya kharakteristika taksanosoderzhashchikh i platinovykh skhem polikhimioterapii v pervoy linii lecheniya raka yaichnikov IV stadii (opyt GVKB im. N.N.Burdenko)
Mel'ko A., Ushakov I., Kira E., Ermolinskiy I.
Znachimost' khromoskopii, endosonografii i uvelichitel'noy endoskopii v reshenii diagnosticheskikh problem predopukholevoy patologii i rannego raka zheludochno-kishechnogo trakta
Poddubnyy B., Kuvshinov Y., Malikhova O., Frolova I.
Opyt primeneniya Regional'noy programmy v g. Krasnodare
Mitashok I.
Which chemotherapy treatments are best for helping people with advanced pancreatic cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Kinaly I.
The first experience in Russia of applying a tumor differentiation protocol in a patient with progressive, radioiodine-refractory BRAF-positive papillary thyroid cancer. Case report
Slashchuk K., Reinberg M., Serzhenko S., Sheremeta M., Nikiforovich P.
Cost-effectiveness of using granulocyte colony-stimulating factor in the treatment of uterine body leiomyosarcomas. A retrospective analysis
Saevets V., Kuzmin N., Shamanova A., Mukhin A., Taratonov A.
Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study
Zhukova L., Bolotina L., Dvornichenko V., Fadeeva N., Ganshina I., Grechukhina K., Hasanova A., Kislov N., Kudryavtsev I., Manikhas A., Musaeva N., Nizhegorodtseva A., Sadikova O., Sakaeva D., Snegovoy A., Stroyakovskiy D., Tjulandin S., Trishkina E., Vladimirova L., Volkov N., Kostalanova Y.
Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Yudina E.
Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Melnikov V.
The effect of hormonal contraception on the risk of breast cancer: A review
Iurova M., Mezhevitinova E., Yakushevskaya O., Rodionov V., Prilepskaya V.
Effective prevention of COVID-19 infection in cancer patients receiving antitumor drug therapy: a regional analysis
Valiachmetova C., Siraev E., Izmailov A.
Opportunities of ICG-fluorescent imaging of lymph nodes during radical cystectomy in patients with bladder cancer: A review
Pavlov V., Urmantsev M., Bakeev M.
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON
Tryakin A., Fedyanin M., Moiseenko F., Mironov O., Stroyakovskiy D., Sokolov N., Orlova S., Mantsyrev E., Sultanbaev A., Teterich A., Babina K., Yukalchuk D., Borzyanitsa S., Isyangulova A., Saidullaeva A., Chernova Y., Bobrova E., Fadeeva N., Chobanu D.
The modified biopsy technique conducting ultrasound bronchoscopy with endosonographic-guided position of the endoscopic instrument in the area of the pathological focus. The results of the first phase of the clinical trial
Pushkarev E., Vazhenin A., Kulaev K., Iusupov I., Zuikov K., Popova I.
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features
Reutova E., Laktionov K.
Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
Brish N., Semiglazova T., Karachun A., Shevkunov L., Ulyanchenko Y., Artemyeva A., Golovanova T., Tkachenko E., Alexeeva Y., Sharashenidze S., Strakh L., Protsenko S., Teletaeva G., Filatova L., Kasparov B., Semiglazov V., Belyaev A.
Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review
Menshikov K., Sultanbaev A., Akhmetgareeva K., Lipatov D.
The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia
Sokolova T., Aleksakhina S., Yanus G., Sultanbaev A., Menshikov K., Lysenko A., Zukov R., Zyuzyukina A., Murunova Y., Rossokha E., Bakharev S., Basova E., Kasmynina T., Shumskaya I., Bakshun Y., Musaeva K., Khasanova A., Dmitriev V., Bolieva M., Gadzaova C., Petrenko O., Maksimov D., Vladimirov V., Goldberg V., Popova N., Kibisheva M., Khamgokov Z., Vasilyev A., Iyevleva A., Imyanitov E.
Cancer of an ectopic parathyroid gland: from diagnosis to treatment (clinical case)
Allakhverdiev A., Malkina N., Noskova K., Grinevich V., Feidorov I., Ketsba A., Bystrovskay E., Embutniex Y., Putova M., Synkova D.
The relationship of GITR, Lag-3 and PD-1 expression with the main indicators of systemic and local immunity in patients with breast cancer
Tabakov D., Zabotina T., Chanturia N., Zakharova E., Vorotnikov I., Selchuk V., Sokolovskiy V., Petrovsky A.
Use of nivolumab for colon cancer with Lynch syndrome
Khakimov G., Tryakin A., Khakimova G.
Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer
Statsenko G., Kurakin V., Plokhotenko I.
The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
Gordeeva O., Kolyadina I., Zhukova L., Gan'shina I., Komov D., Meshcheriakov A.
Pneumonectomy with carinal resection in patients with non-small cell lung cancer: short and long-term results
Dadyev I., Davydov M., Abdullaev A., Kulik I., Ambalova Z., Akhmedov P., Anokhin A., Karasheva B.
The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer
Karabina E., Lubchenko L., Garunov A.
Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?
Zhukova L., Ganshina I., Khatkova E., Tikhomirova T., Kondratyeva O.
Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case
Kolyadina I., Ganshina I., Zhukova L., Abdullaev A., Andreeva Y., Danzanova T., Sinyukova G., Komov D., Kozlov N., Filonenko D., Gordeeva O., Lubennikova E.
Clinico-morphological predictors and treatment outcomes in cervical stump cancer
Usmanova L., Kuznetsov V., Mustafina E., Barinov V., Bokin I., Knyazev R., Akhmedova M.
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.
Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene
Ryazhenov V., Gorokhova S.
Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council
Rumyantsev P., Gorbunova V., Podvyaznikov S., Zhukov N., Isaev P., Krylov V., Mudunov A., Rodichev A., Shavarova E.
The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia
Bolotina L., Manziuk L., Gorbunova V., Kovalenko E., Mukhametshina G., Khasanova A., Vladimirova L., Mitashok I., Prokofyeva E., Evstigneeva I., Andreyashkina I., Abramova N., Popova I., Karabina E., Teterich A., Gaysina E., Chubenko V., Limareva S., Tikhanovskaya N., Storozhakova A., Samaneva N., Svetitskaya Y., Snezhko T., Kalabanova E.
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia)
Khokhlova S., Gorbunova V., Lyubchenko L., Imyanitov E.
Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)
Fedyanin M.
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.
Radiation-induced lung injury in breast cancer patients after breast conservation therapy
Trofimova O., Tkachev S., Ivanov S., Utkina V., Cheban O., Glebovskaya V.
Second primary cancer in patients with head and neck squamous cell carcinoma (review of the literature)
Agabekyan G., Kropotov M., Saprina O., Stelmakh D., Park M.
Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I?
Kolyadina I., Poddubnaya I., Trofimova O., Frank G., Karseladze A., Komov D.
Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards
Vozmozhnosti lekarstvennoy terapii neoperabel'noy i metastaticheskoy bazal'no-kletochnoy kartsinomy kozhi
Levchenko E.
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.
Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases
Sekacheva M., Bagmet N., Polishchuk L., Glazova O., Zaklyazminskaya E., Skripenko O.
Current approach to adjuvant therapy for breast cancer (a review)
Conte P., Guarneri V.
Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
Zhukova L., Abramov M., Vakhabova Y., Lud A., Obukhov A., Lichinitser M.
Rol' i mesto tsetuksimaba v 1-y linii terapii metastaticheskogo kolorektal'nogo raka
Kopp M., Koroleva I.
Tayverb/Tyverb (lapatinib) – pervyy dvoynoy anti-ErbB1(EGFR)i anti-ErbB2(HER2)-ingibitor v lechenii mestno-rasprostranennogo i metastaticheskogo raka molochnoy zhelezy zaregistrirovan v Rossiyskoy Federatsii
Ul'trazvukovye kriterii effektivnosti lecheniya raka yaichnikov
Sinitsina M., Chekalova M., Gorbunova V., Kedrova A., Mazyrko M.
Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy?
Ptushkin V.
Osobennosti kliniko-morfologicheskikh kharakteristik i lecheniya retsidiva raka yaichnikov IV stadii
Mel'ko A., Ushakov I., Kira E., Shamkina V., Gaytukieva R.
Segmentarnaya rezektsiya nizhney chelyusti s odnomomentnoy rekonstruktsiey u bol'nykh zlokachestvennymi novoobrazovaniyami polosti rta
Kropotov M., Sobolevskiy V.
Aromazin: printsip deystviya
Imyanitov E.
Farmorubitsin v klinicheskoy praktike
Gorbunova V.
Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere
Chevardov N., Tolstykh L., Puzakov K., Potapov Y.
401 - 476 的 476 信息 << < 1 2 3 4 5 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语